Comparison 9. Burch colposuspension versus MMK.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Number with incontinence within first year (subjective)	2	135	Risk Ratio (M‐H, Fixed, 95% CI)	0.73 [0.28, 1.95]
1.1 Urodynamic diagnosis	1	105	Risk Ratio (M‐H, Fixed, 95% CI)	0.35 [0.10, 1.26]
1.2 Symptom diagnosis	1	30	Risk Ratio (M‐H, Fixed, 95% CI)	7.0 [0.39, 124.83]
2 Number with incontinence after first year but before five years (subjective)	4	353	Risk Ratio (M‐H, Fixed, 95% CI)	0.72 [0.52, 0.99]
2.1 Urodynamic diagnosis	2	185	Risk Ratio (M‐H, Fixed, 95% CI)	0.38 [0.18, 0.76]
2.2 Symptom diagnosis	2	168	Risk Ratio (M‐H, Fixed, 95% CI)	0.94 [0.66, 1.34]
3 Number with incontinence not improved after first year but before five years (subjective)	2	218	Risk Ratio (M‐H, Fixed, 95% CI)	0.42 [0.22, 0.80]
3.1 Urodynamic diagnosis	1	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.2 Symptom diagnosis	1	138	Risk Ratio (M‐H, Fixed, 95% CI)	0.42 [0.22, 0.80]
4 Number with incontinence within the first year (objective)	2	135	Risk Ratio (M‐H, Fixed, 95% CI)	0.58 [0.22, 1.50]
4.1 Urodynamic diagnosis	1	105	Risk Ratio (M‐H, Fixed, 95% CI)	0.35 [0.10, 1.26]
4.2 Symptom diagnosis	1	30	Risk Ratio (M‐H, Fixed, 95% CI)	1.5 [0.29, 7.73]
5 Number with incontinence after first and before five years (objective)	3	215	Risk Ratio (M‐H, Fixed, 95% CI)	0.64 [0.39, 1.05]
5.1 Urodynamic diagnosis	2	185	Risk Ratio (M‐H, Fixed, 95% CI)	0.44 [0.25, 0.77]
5.2 Symptom diagnosis	1	30	Risk Ratio (M‐H, Fixed, 95% CI)	7.0 [0.98, 50.16]
6 Length of hospital stay (days)	1	80	Mean Difference (IV, Fixed, 95% CI)	‐1.10 [‐1.74, ‐0.46]
6.1 Urodynamic diagnosis	1	80	Mean Difference (IV, Fixed, 95% CI)	‐1.10 [‐1.74, ‐0.46]
6.2 Symptom diagnosis	0	0	Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Time to catheter removal (days)	3	112	Mean Difference (IV, Fixed, 95% CI)	‐6.35 [‐9.15, ‐3.56]
7.1 Urodynamic diagnosis	1	80	Mean Difference (IV, Fixed, 95% CI)	‐4.9 [‐7.95, ‐1.85]
7.2 Symptom diagnosis	2	32	Mean Difference (IV, Fixed, 95% CI)	‐14.0 [‐20.98, ‐7.02]
8 Number of perioperative surgical complications	1	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.2 [0.01, 4.04]
8.1 Urodynamic diagnosis	1	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.2 [0.01, 4.04]
8.2 Symptom diagnosis	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
9 Number with de novo urge symptoms and urge incontinence	1	105	Risk Ratio (M‐H, Fixed, 95% CI)	0.63 [0.11, 3.62]
9.1 Urodynamic diagnosis	1	105	Risk Ratio (M‐H, Fixed, 95% CI)	0.63 [0.11, 3.62]
9.2 Symptom diagnosis	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
10 Number with de novo detrusor overactivity	2	185	Risk Ratio (M‐H, Fixed, 95% CI)	0.53 [0.20, 1.36]
10.1 Urodynamic diagnosis	2	185	Risk Ratio (M‐H, Fixed, 95% CI)	0.53 [0.20, 1.36]
10.2 Symptom diagnosis	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
11 Number with voiding difficulty	1	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.27 [0.08, 0.90]
11.1 Urodynamic diagnosis	1	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.27 [0.08, 0.90]
11.2 Symptom diagnosis	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
12 Number with new or recurrent prolapse	2	185	Risk Ratio (M‐H, Fixed, 95% CI)	6.75 [0.84, 54.31]
12.1 Urodynamic diagnosis	2	185	Risk Ratio (M‐H, Fixed, 95% CI)	6.75 [0.84, 54.31]
12.2 Symptom diagnosis	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
13 Number with repeat anti‐incontinence surgery	1	105	Risk Ratio (M‐H, Fixed, 95% CI)	0.47 [0.04, 5.05]
13.1 Urodynamic diagnosis	1	105	Risk Ratio (M‐H, Fixed, 95% CI)	0.47 [0.04, 5.05]
13.2 Symptom diagnosis	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]